Search

everythinglearnresearchcommunity

for

Search:↓

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Finasteride may help some women with hair loss, but better options exist.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Artificial hair implants can quickly improve looks and life quality, but they have risks like infection and early fiber loss, so more research is needed to confirm their safety and effectiveness.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Saw palmetto is not proven to improve urinary flow, prostate size, or hair loss.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

New effective scar treatments are urgently needed due to the current options' limited success.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

PLD is an effective and safer alternative for treating breast cancer.